×

About Us
Technologies
Programs
- Oncology
- Diabetes
Clinical Trials
Investors
News
Contact

MENU

Practitioner’s Advice

September 29, 2015Blog Posts

Search

Note: When you click on media articles, a new page will open indicating that you are leaving the Genprex, Inc. website and entering a third-party website not affiliated with Genprex Inc. or any of its affiliates. No information contained in a linked site has been endorsed or approved by Genprex, Inc. and Genprex, Inc. is not responsible for the content of such third-party websites.

Categories

Acclaim 1
Acclaim 2
Acclaim 3
Blog Posts
Media Coverage
Press Releases

Recent Posts

Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy at the 2024 EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
Genprex Collaborators to Present Positive Preclinical Data on Reqorsa® Gene Therapy at the Society for Immunotherapy of Cancer 2024 Annual Meeting
Genprex – Developing Novel Gene Therapies in Cancer with Tumor Suppressor Genes and Diabetes Converting Alpha Cells into Beta Cells to Produce Insulin
Genprex Featured in CEO/CFO Magazine Discussing Novel Gene Therapies for Cancer and Diabetes
Genprex Announces Formation of Mesothelioma Clinical Advisory Board

Archives

Tag Cloud

Acclaim-1 Acclaim-2 Acclaim-3 Aldevron Austin Business Journal Big Biz Show Board of Directors cancer CEO Clinical Trials conference Conferences Diabetes Dr. Gittes Events Fast Track Fast Track Designation FDA FDA Fast Track Fitness Gene Therapies gene therapy Health Immunotherapies Immunotherapy KOL Event Manufacturing Media Coverage Nonviral Delivery System Nonviral Vector NSCLC Oncology Oncoprex Preclinical Data Presentation Presentations Reqorsa Russell Index Shareholder Letter Tagrisso Tips TUSC2 Type 1 Diabetes University of Pittsburgh Video

Genprex, Inc. is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes.

(877) 774-GNPX (4679)

3300 Bee Cave Road, Suite 650-227 Austin, TX 78746

Quick Links

About Us
Clinical Trials
Investors
Downloads
Press Releases

X
Facebook
LinkedIn

Latest News

Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy at the 2024 EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics Oct 10
Genprex Collaborators to Present Positive Preclinical Data on Reqorsa® Gene Therapy at the Society for Immunotherapy of Cancer 2024 Annual Meeting Oct 7
Genprex – Developing Novel Gene Therapies in Cancer with Tumor Suppressor Genes and Diabetes Converting Alpha Cells into Beta Cells to Produce Insulin Sep 23
Genprex Featured in CEO/CFO Magazine Discussing Novel Gene Therapies for Cancer and Diabetes Sep 23

Designed and Secured by Barsec

Copyright ©2024 all rights reserved.
Home - Privacy Policy - Terms of Use